Endpoint definition
↥| Name | H7_USEOFEYEANTIALLERGENS |
|---|---|
| Long name | Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis) |
| Medicine purchases: ATC codes | S01GX |
| Level in the ICD-hierarchy | 4 |
| First defined in version | DF2 |
Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)
conjunctivitis: Inflammation of the conjunctiva of the eye. [ NCIT:P378 ]
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 9431 | 7237 | 2194 |
| Unadjusted prevalence (%) | 4.35 | 5.89 | 2.33 |
| Mean age at first event (years) | 39.12 | 40.01 | 36.18 |
| Case fatality at 5-years (%) | 0.47 | 0.40 | 0.68 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 2.0 | 2.0 | 1.0 |
| Recurrence at 6 months (%) | 23.31 | 25.03 | 18.62 |
Survival analyses between endpoints
↥Plot
before Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)
after Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)
Loading survival analyses plot…
Table
Loading survival analyses table…